Dawn Kernaghan

Dawn Kernaghan is a CMC Regulatory Director at AstraZeneca. Previously, they served as a Senior Scientist in Global Technical Operations, focusing on analytical technical leadership in late-stage commercial method validation and regulatory authoring. Dawn's experience includes roles as a Principal Scientist and Scientist II at AstraZeneca, as well as positions at MedImmune and the University of Maryland School of Medicine. They hold a B.S. in Chemistry/Biochemistry from Marist University and an M.S. in Chemistry from the University of Maryland.